Provided is a therapeutic agent for Lewy body disease comprising (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydtuthran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-onerepresented by formula (I)or a pharmaceutically acceptable salt thereof.(see above formula)